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Background. The relationship between smoking and suicide remains controversial.
Method. A total of 16 282 twin pairs born before 1958 in Finland and alive in 1974 were queried with detailed health and
smoking questionnaires in 1975 and 1981, with response rates of 89% and 84%. Smoking status and dose, marital,
employment, and socio-economic status, and indicators of psychiatric and somatic illness were assessed at both time
points. Emergent psychiatric and medical illness and vital status, including suicide determined by forensic autopsy,
were evaluated over 35-year follow-up through government registries. The association between smoking and suicide
was determined in competing risks hazard models. In twin pairs discordant for smoking and suicide, the prospective
association between smoking and suicide was determined using a matched case–control design.
Results. Smokers had a higher cumulative suicide incidence than former or never smokers. Heavy smokers had sign-
iﬁcantly higher suicide risk [hazard ratio (HR) 3.47, 95% conﬁdence interval (CI) 2.31–5.22] than light smokers (HR
2.30, 95% CI 1.61–3.23) (p = 0.017). Compared with never smokers, smokers, but not former smokers, had increased sui-
cide risk (HR 2.56, 95% CI 1.43–4.59), adjusting for depressive symptoms, alcohol and sedative–hypnotic use, and exclud-
ing those who developed serious somatic or psychiatric illness. In twin pairs discordant for smoking and suicide, suicide
was more likely in smokers [odds ratio (OR) 6.0, 95% CI 2.06–23.8].
Conclusions. Adults who smoked tobacco were more likely to die by suicide, with a large, dose-dependent effect. This
effect remained after consideration of many known predictors of suicide and shared familial effects, consistent with the
hypothesis that exposure to tobacco smoke increases the risk of suicide.
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Introduction
Tobacco smoking has been associated with suicide in a
number of studies (Hemenway et al. 1993; Tverdal et al.
1993; Doll et al. 1994; Miller et al. 2000a; Tanskanen et al.
2000; Iwasaki et al. 2005; Lucas et al. 2013; Schneider
et al. 2014), but because smokers have higher preva-
lence of chronic somatic, psychiatric and addictive dis-
orders that confer independent risk for suicide (Grant
et al. 2004; Hasin et al. 2005; Hughes, 2008; Lawrence
et al. 2009), interpretation of this association remains
highly controversial. Some studies have reported that
the association between tobacco smoking and com-
pleted suicide is independent of potential confounds
such as co-morbid psychiatric illness (e.g. depression)
and excessive alcohol use (Tanskanen et al. 2000;
Iwasaki et al. 2005; Lucas et al. 2013; Schneider et al.
2014), while others report that the association is due
to heavy alcohol use and psychiatric co-morbidity
(Hemmingsson & Kriebel, 2003). Consensus on the
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nature of the association is needed and could inﬂuence
suicide risk assessment and broaden our understand-
ing of the harms of tobacco smoking. To reduce the
public health burden of suicide mortality, prospective
and longitudinal research is needed to improve predic-
tion and identify modiﬁable risk factors for suicide
(Franklin et al. 2017). To investigate whether tobacco
smoking is independently and possibly etiologically
associated with suicide, we evaluated the prospective
association between tobacco smoking and change in
smoking behavior with subsequent suicide over
35 years in a large, population-based twin cohort, con-
trolling for multiple confounders.
Method
The Finnish Twin Cohort (Kaprio & Koskenvuo, 2002)
includes 16 282 twin pairs alive and aged at least 18
years in 1975. The cohort is made up of 4184 monozy-
gotic (MZ) and 9257 dizygotic (DZ) pairs, with 2841 of
unconﬁrmed zygosity due to non-response or incon-
sistency in response to zygosity queries, is 49.4%
female and had an average age of 35.1 years in 1974.
Cohort members received extensive health question-
naires in 1975 and 1981. Response rates were 89%
and 84%, respectively.
Smoking status categories
Smoking was categorized as ‘never’ (fewer than 100
cigarettes lifetime), ‘former’ or ‘active’ smokers in
1975. Further, if smoking status was unchanged at the
1981 assessment, participants were classiﬁed as ‘persist-
ent never smokers’, ‘persistent former smokers’ or ‘per-
sistent active smokers’. Participants who were active
smokers in 1975 and former smokers in 1981 were clas-
siﬁed ‘quitters’; those who were non-smokers in 1975
and smokers in 1981 were ‘initiators’. The category of
‘active’ smokers included both daily and non-daily
smokers. Daily smokers reported number of cigarettes
smoked per day (cpd) at each time point, and those
who smoked >20 cpd were considered heavy smokers.
Detailed information on potential confounders of the
relationship between smoking and suicide was col-
lected by questionnaire in 1975 and 1981 and through
government registry query for the 35-year follow-up
period. Questionnaires included information on well-
established predictors for suicide such as marital,
employment and socio-economic status, physician-
diagnosed somatic illness, depressiveness, and alcohol
and sedative–hypnotic medication use.
Respondents completed the four-item (range 4–20)
Life Satisfaction Scale (LSS) in 1975 and 1981 to assess
pre-existing depressiveness as a proxy for depressive
illness. They were asked to rate on a ﬁve-point Likert
scale interest in life (1 = very interesting, 5 = very bor-
ing), happiness (1 = very happy, 5 = very sad), ease of
living (1 = very easy, 5 = very hard) and feeling of lone-
liness (1 = not at all lonely, 5 = very lonely). LSS scores
have been linearly correlated with concurrently
assessed Beck Depression Inventory (BDI) ratings in a
general population sample (r = 0.60), and were found
to be highly predictive of development of depressive
illness in a 15-year prospective longitudinal study in
a healthy community sample [dissatisﬁed (LSS 12–20)
v. satisﬁed (LSS 4–6); odds ratio (OR) 6.7, 95% conﬁ-
dence interval (CI) 4.2–10.9] (Koivumaa-Honkanen
et al. 2004a, b). LSS scores have demonstrated signiﬁcant
association with completed suicide over a 20-year
follow-up, independent of age, sex, alcohol use, smok-
ing status and physical activity (Koivumaa-Honkanen
et al. 2001). In a mixed clinical sample, LSS scores
were associated with anxiety, depressive and psychotic
disorder diagnoses, and with use of antidepressant and
sedative–hypnotic medications, alcohol and drug use,
and BDI scores (Koivumaa-Honkanen et al. 1996).
Sedative–hypnotic use was self-rated in 1975 and 1981
on a ﬁve-point scale and used in the analysis as no v. any
use. Excess alcohol use was self-rated at these time
points, deﬁned as >42 g/day for men and >28 g/day for
women, and binge drinking deﬁned as >1 alcohol-
related blackout in the prior year (Carlsson et al. 2003).
Psychiatric and somatic co-morbidity was assessed
with national registry queries. Receipt of antipsychotic
medication at any time from 1975 to 2004 and receipt
of antidepressant medication from 1995 to 2004 was
identiﬁed through the Social Insurance Institution
(SII) of Finland (Cannon et al. 1998). Antidepressant
use was used as an indicator of depressive illness
because the psychiatric diagnosis for which an anti-
depressant was prescribed was not systematically
recorded until 2000. Eligibility for psychiatric disability
pension at any time from 1975 to 2004 was identiﬁed
through Finnish pension registers (Harkonmaki et al.
2008). Twins with smoking-related somatic illnesses
that increase suicide risk, such as cancer, diabetes, car-
diovascular and pulmonary diseases such as emphy-
sema, asthma and chronic bronchitis, were identiﬁed
using self-report and Finnish medical registers to
2011. People with psychiatric or somatic illness were
removed from the sample to create a healthy subcohort
without tobacco-related somatic conditions for some
sensitivity analyses (see Tables 3 and 4).
Mortality
Information on vital status was obtained from the
Population Register Center, which tracks all vital events
in Finland. Dates of death and emigration were obtained
to 2011. Causes of death were obtained from Statistics
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Finland. Suicide cases were identiﬁed from International
Classiﬁcation of Diseases rubrics. Forensic autopsy
by specialist forensic pathologists with support from
forensic chemical analyses is mandatory in Finland for
sudden and unexpected deaths. Thus the diagnosis
of suicide on ofﬁcial death certiﬁcates in Finland is
considered reliable and valid (Varnik et al. 2012).
Data analyses and statistical methods
Standard statistical methods were used for descriptive
analyses, taking into account cohort sampling based on
twin pairs. As twins within a pair are not statistically
independent observations, robust estimates of stand-
ard errors were obtained for individual-based analyses
(Williams, 2000).
We ﬁrst evaluated suicide rates by smoking status
using a competing risk model. Because smoking
causes diseases that may cause a cohort member to
die before she/he might have died by suicide, we
used competing-risks regression models in the survival
data analysis instead of Cox regression to investigate
the effect of smoking status on risk of death by suicide
(Lau et al. 2009; Haller et al. 2013). Mortality not due to
suicide was deﬁned as the competing risk and we
modeled the subdistribution hazard using Stata’s
stcrreg procedure. We tested the assumption of pro-
portionality behind competing-risk regression by a
covariate × time interaction. Data were censored by
date of emigration or end of follow-up (31 December
2011). We then evaluated whether this association
remained after excluding persons with major psychi-
atric or somatic illness. In models excluding persons
with major psychiatric or somatic illness, we then
evaluated the association between smoking behavior
and suicide in an age-adjusted model controlling for
factors that may be independently related to suicide.
We planned to retain age, sex, LSS scores, sedative–
hypnotic medication use, excess daily alcohol use
and binge alcohol use in ﬁnal models. Other covariates
were retained if signiﬁcantly associated with suicide.
To further explore whether the association between
smoking and suicide remained after controlling for
genetic and familial suicide risk factors, we investi-
gated the relationship of smoking status with suicide
in twin pairs discordant for both suicide and active
smoking. Using a matched case–control design, we
tested ORs using McNemar’s test, and then we ran a
pairwise survival model. Analyses were run in Stata/
SE 12.1 (USA) on 9 July 2013.
Results
There were 313 suicides in the cohort between 1976 and
2011. Among 26 020 respondents with known smoking
status in 1975, there were 232 suicides (see Table 1).
Forensic autopsy was conducted in 25% of all deaths in
the cohort and in 98% (228/232) of suicide deaths. The
overall mortality of the twin cohort members did not dif-
fer from that of the Finnish population (Kaprio, 2013).
Prospective association between tobacco smoking in
1975 and completed suicide to 2011
Those who reported being active smokers in 1975 had a
higher risk of suicide from 1976 to 2011 than those who
reported never smoking [hazard ratio (HR), 2.59, 95%
CI 1.87–3.62], with little variation by sex or age
(Table 2). The proportionality assumption was not vio-
lated (time × smoking interaction p = 0.35, time × sex inter-
action p = 0.46). In addition, risk for suicide was elevated
in those who were baseline (1975) smokers but with
follow-up initiated from 1 January 1986 with follow-up
to 2011 (1986–2011, 160 suicides, HR 2.89, 1.94–4.31).
Correspondingly, an analysis in cohort members alive
as of 1 January 1996 with follow-up until the end of
2011 showed an association with smoking at baseline
(1975) (1996–2011, 72 suicides, HR 2.73, 1.52–4.88).
Heavy smokers in 1975 had higher suicide risk over 35
years of follow-up (HR 3.47, 95% CI 2.31–5.22) than
daily smokers who smoked less (HR 2.3, 95% CI 1.61–
3.23) (p = 0.017, test of homogeneity of regression coefﬁ-
cients), with never smokers as overall reference (HR 1).
Age of smoking initiation among active smokers, i.e. ini-
tiation before age 18 years compared with initiating later,
was not associated with suicide risk (data not shown).
Both non-daily and daily smokers had elevated risk of
subsequent suicide over never smokers that did not differ
signiﬁcantly from each other when modeled separately
(HR 2.44, 95% CI 1.29–4.62, and HR 2.60, 95% CI 1.87–
3.62, respectively) (not shown in Table 2). Active smokers
had a higher cumulative suicide incidence than never
smokers at every age (except the oldest age group
where the HR point estimate is high but the sample size
is small, limiting power to detect an effect) (Table 2,
Fig. 1). Active male smokers had the highest suicide risk
(70/100 000 person-years), and never-smoking women
the lowest (7.3/100 000 person-years). Those who had
quit smoking did not have elevated suicide risk, though
HR point estimates were greater than unity (Table 2).
Prospective association of tobacco smoking in 1975
on suicide risk to 2011, excluding those with
co-morbid psychiatric and medical conditions
The risk of suicide to 2011 remained elevated among
active smokers in 1975 relative to never smokers
when those who qualiﬁed for state reimbursable
antipsychotic medication (1964–2004) or psychiatric
disability pension (1975–2004), or both, 34 of 232 sui-
cides (14.6%), were excluded from the cohort (HR
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2.77, 95% CI 1.93–3.99) (n = 198 suicides). When those
who reported excess alcohol use in 1975 (542 g/day
for men and 528 g/day for women) were removed,
4% of the sample, n = 800 (7%) men and n = 187 (2%)
women, the risk of suicide remained elevated
among active smokers to 2011 (HR 2.56, 95% CI
1.62–4.04). The risk of suicide also remained elevated
among active smokers (HR 2.30, 95% CI 1.43–3.68)
after excluding those broadly deﬁned as ill, aged
over 60 years, or at high risk of somatic disease
prior to 1983 (Kujala et al. 2002) (n = 123 suicides)
(Table 3). Excluding those with incident malignancy
to 2011 according to the Finnish Cancer Registry (n
= 4500, with 2739 deaths, 15 suicides), the risk of sui-
cide among smokers remained elevated in the remain-
ing healthy cohort of 21 520 persons (HR 2.50, 95% CI
1.80–3.49).
Multivariable analyses
To evaluate the impact of additional potential con-
founding factors, in cohorts that did and did not
exclude those with co-morbid psychiatric and medical
conditions as deﬁned above, we ran models with
smoking status in 1975, sex and one additional variable
to see whether inclusion of the variable inﬂuenced the
association between smoking status in 1975 and sui-
cide to 2011. We considered a decrease of 5% or
more in the HR for suicide (HR 2.59 for active smokers,
see Table 2) to be sufﬁciently large for the variable to
be retained for additional analyses. When added to
the model, neither socio-economic variables nor
employment status substantially affected the associ-
ation of smoking on suicide.
LSS score, excess daily alcohol use, binge alcohol
use, and sedative–hypnotic medication use in 1975
modestly attenuated the association of active smoking
with subsequent suicide (HRs 2.23–2.44) and were
retained in the model.
In sex-adjusted analysis, LSS score in 1975 was
strongly associated with elevated suicide risk (HR
1.14 per unit LSS score increase, 95% CI 1.10–1.18). In
a categorical analysis, when those in the dissatisﬁed
and very dissatisﬁed categories were compared with
the satisﬁed category, suicide risk was elevated (HRs
2.51 and 4.25, respectively).
Table 1. Characteristics of cohort members with smoking status in 1975 by vital status in 2011
Alive Non-suicide deaths Suicides All
Total N 17 876 7912 232 26 020
Smoking status, n (%)
Never smoker in 1975 8752 (49.0) 3649 (46.1) 51 (22.0) 12 452 (47.9)
Former smoker in 1975 2846 (15.9) 1400 (17.7) 35 (15.1) 4281 (16.5)
Active smoker in 1975 6278 (35.1) 2863 (36.2) 146 (62.9) 9287 (35.7)
Sex, n (%)
Men 8217 (46) 4297 (54) 182 (78.5) 12 696 (49)
Women 9659 (54) 3615 (46) 50 (21.5) 13 324 (51)
Mean age at baseline, years (S.D.)
Men 29.8 (8.5) 46.9 (14.2) 33.3 (12.3) 35.6 (13.5)
Women 30.6 (9.6) 54.0 (14.4) 30.0 (9.9) 36.3 (15.2)
Marital status, % married
Men 52.5 70.1 45.1 58.4
Women 55.3 52.9 52 54.7
Binge drinking, %
Men 40.3 39.0 61.3 40.2
Women 10.4 4.7 22.0 8.9
Mean life satisfaction score (S.D.)
Men 8.5 (2.8) 9.0 (3.2) 10.0 (3.2) 8.8 (2.9)
Women 8.5 (2.9) 9.2 (3.0) 9.9 (3.7) 8.7 (3.0)
Psychiatric disability pension by 2004, %
Men 3.5 6.5 8.7 4.6
Women 4.9 5.9 21.7 5.2
State reimbursable antipsychotic medication, %
Men 2.1 3.2 4.4 2.5
Women 2.7 4.4 26.0 3.2
S.D., Standard deviation.
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Excess alcohol use in 1975 was also associated with
elevated suicide risk over the 35-year follow-up period
in univariate analyses assessed as sex-speciﬁc excess
alcohol use (542 g/day for men and 528 g/day for
women) (HR 2.02, 95% CI 1.05–3.92), and as binge
drinking, deﬁned as more than one alcohol-associated
blackout in the prior year (HR 2.29, 95% CI 1.43–3.64)
(see Table 4).
Effect of change in smoking behavior between 1975
and 1981 and risk for subsequent suicide
Persistent active smokers (smokers at both time points)
had the highest risk for suicide. Those who initiated
smoking between the surveys had an increased suicide
risk compared with those who were stable non-
smokers at both time points (Table 4). Smokers who
quit between 1975 and 1981 had a lower point esti-
mate for suicide risk (HR 2.28) compared with persist-
ent smokers (HR 3.27), but the number of suicides
was only 11, so power was low for this comparison
(p = 0.19).
The HR for suicide in active smokers in 1975 and
1981 was reduced from 3.27 to 2.90 and 2.85, respect-
ively, in models containing problem alcohol use
variables but remained highly signiﬁcant. In the multi-
variable analysis of smoking and these potential con-
founders, the HR for suicide in active smokers
relative to never smokers dropped to 2.14 (95% CI
1.33–3.45) in the model with all cohort members (n =
138 cases from 1981 onwards in 1810 persons). In
this model, LSS in 1975 and 1981 and binge drinkingT
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Fig. 1. Cumulative incidence of suicide by smoking status.
Cumulative incidence of suicide by smoking status in 1975
estimated from a competing risk survival model adjusted for
sex and age. The upper curve (––) represents active smokers
in 1975, the middle curve (––) represents former smokers in
1975 and the bottom curve (---)represents never smokers in
1975. Based on 26 020 persons in the cohort in 1975 and 232
suicides to 2011.
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were also independently associated with suicide. In a
model with the same covariates that excluded persons
with active or future use of antipsychotic medications
or disability pension due to psychiatric illness, the
HR for active smokers was 2.56 (95% CI 1.43–4.59)
(Table 4).
Effect of smoking on subsequent suicide risk among
those who received no prescriptions for
antidepressant medications
Antidepressant prescription data were available from
1995 to 2004, and recording of diagnosis for which
antidepressant medication was prescribed began after
the year 2000. Thus we ran analyses of the subcohort
with no antidepressant medication prescriptions over
that 10-year period as a sensitivity analysis in a sample
enriched for those without affective disorders, e.g.
depression diagnosed by a physician and treated. In
a competing risk model in the subcohort of 22 584 per-
sons alive on 1 January 1995 with smoking data and
76 suicides between 1995 and 2011, compared with
never smokers, active smokers had a HR of 2.91 (95%
CI 1.63–5.17) for suicide with no adjustments or exclu-
sions other than age or sex. In this subcohort, 18 470
persons received no antidepressant prescriptions,
1676 received prescriptions for antidepressant medica-
tions for 3–9 months, and 2438 received prescriptions
for antidepressant medications for more than 9
months. Among never users of antidepressants, there
were 40 suicides, nine among never smokers, seven
among former smokers, and 24 among active smokers
(in 1975); among them, the risk of suicide was 2.50
(95% CI 1.15–5.42) for active smokers. If we further
excluded those with antipsychotic use or disability
pension for psychiatric illness, the HR for active smo-
kers among those who received no prescriptions for
antidepressant medication was 3.26 (95% CI 1.32–
8.08). Further adjustment for pre-existing depressive-
ness (LSS score) in 1975, binge alcohol use in 1975, or
sedative–hypnotic medication use did not signiﬁcantly
change the risk (HR 3.12, 95% CI 1.20–8.13).
Assessed by smoking change between 1975 and
1981, the risk estimate (HR) for suicide 1995–2011
among those who did not receive antidepressant medi-
cation (1995–2004) was 4.85 for persistent active smo-
kers (p = 0.017), 7.20 (p = 0.006) for those who initiated
smoking between 1975 and 1981, and 2.78 for those
who quit smoking (p = 0.23) compared with consistent
never smokers. This model excluded those with anti-
psychotic use or disability pension for psychiatric ill-
ness, and adjusted for pre-existing depressiveness
(LSS score 1975 and 1981), binge alcohol use 1975
and 1981, and self-reported sedative–hypnotic medica-
tion use in 1975 (data not shown).Ta
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Within-pair analysis of smoking and suicide
To further control for shared genetic and environmen-
tal risks for suicide, we evaluated twin pairs doubly
discordant for smoking and suicide by ascertaining
twin pairs in which one twin died by suicide whereas
the co-twin was alive in 2011 or had died from another
cause, in which smoking status was known for both
co-twins in 1975, and in which one twin was an active
smoker in 1975 while the co-twin was a never smoker.
In all, 28 twin pairs were doubly discordant (eight MZ,
18 DZ, two uncertain zygosity). Of these, the twin who
committed suicide was an active smoker in 24 pairs
(seven MZ, 15 DZ, two uncertain zygosity), and the
never-smoking twin was alive or died from another
cause, while the converse was true for four pairs [over-
all OR 6 (24/4), 95% CI 2.1–23.8; OR 7 for MZ pairs,
McNemar p = 0.034; OR 5 for DZ pairs, p < 0.005].
A test for homogeneity of ORs across zygosity groups
indicated no difference by zygosity (p = 0.80). Likewise,
the risk estimates did not differ by sex (men OR 5.67,
women OR 7.00, p = 0.86).
Among the doubly discordant pairs, the co-twin was
alive at the end of follow-up in 22 pairs, while in ﬁve
pairs, the co-twin had died from natural causes. Only
one pair (MZ) was such that the co-twin, who was
an occasional smoker, had death from accidental poi-
soning (not considered suicide), while the suicide
case was the never smoker. We ran a pairwise survival
model in which the hazard for the smoking twins was
compared with the hazard of the non-smoking
co-twin, and the HR was 5.5 (95% CI 1.90–16.0, p =
0.002), with HRs of 7.0 and 4.3 for MZ and DZ pairs,
respectively.
Discussion
In this large, population-based sample, active tobacco
smokingwasdose-dependently associatedwith increased
risk of suicide, while former smoking was not, in a tem-
poral sequence consistent with a causal relationship.
This association held for all age groups, except the
oldest, which was underpowered. The association
Table 4. Risk of death by suicide from 1982 to 2011 by stability of smoking behavior from 1975 to 1981a
Multivariate model HR (95% CI)
Variablesb All Men Women
Age–sex adjusted only
without other covariates or
mental health exclusions
Persistent never smokers: reference 1.00 1.00 1.00 1.00
Initiators 1.42 (0.56–3.61) 1.78 (0.65–4.93) 0.00 (0.00–0.00)c 2.31 (1.14–4.70)
Persistent former smokers 1.66 (0.76–3.64) 1.48 (0.58–3.80) 2.96 (0.78–11.2) 1.56 (0.83–2.95)
Quitters 2.13 (0.99–4.60) 2.21 (0.89–5.45) 1.97 (0.41–9.56) 2.28 (1.23–4.22)
Persistent active smokers 2.56 (1.43–4.59) 2.63 (1.30–5.35) 2.35 (0.82–6.76) 3.27 (2.11–5.08)
Use of sedative–hypnotic medication 2.10 (1.17–3.80) 2.37 (1.23–4.55) 1.40 (0.39–5.00)
Excess alcohol use 1.57 (0.80–3.06) 1.77 (0.90–3.51) 0.00 (0.00–0.00)c
Binge drinking 2.18 (1.34–3.53) 2.07 (1.25–3.43) 4.30 (1.20–15.32)
Life satisfaction scale score in 1975 1.06 (0.99–1.14) 1.08 (1.01–1.16) 0.97 (0.78–1.21)
Life satisfaction scale score in 1981 1.05 (0.99–1.12) 1.02 (0.95–1.09) 1.19 (1.07–1.34)
Suicides, n 102 82 20 153
Total N 15 231 7773 7458 21 304
HR, Hazard ratio; CI, conﬁdence interval.
a The ﬁrst column shows a fully adjusted model that includes mental health-relevant covariates and sex and excludes per-
sons with antipsychotic medication use and disability pension due to mental disorders (see Method for details). Results are
presented for men and women together in the ﬁrst column, and then adjusting for covariates separately for men and women
in the second and third columns. The age–sex-adjusted model without covariates or exclusions is shown in the last column
for comparison.
b Persistent never smokers were non-smokers in 1975 and 1981. Initiators were non-smokers in 1975 and smokers in 1981.
Persistent former smokers were former smokers in 1975 and 1981. Quitters were smokers in 1975 and non-smokers in 1981.
Persistent active smokers were smokers in both 1975 and 1981. Data for use of sedative–hypnotic medication, excess alcohol
use and binge drinking were from the 1975 assessment. Life satisfaction is entered as a continuous variable, range 4–20, with
higher scores indicating greater dissatisfaction.
c The HRs are based on zero cases after excluding those with psychiatric register records.
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remained after excluding those with reliably assessed
antipsychotic and antidepressant medication use, psy-
chiatric disability and tobacco-related somatic illness,
including cancer. It also remained after adjusting for
pre-existing depressiveness as a proxy for depressive ill-
ness, sedative–hypnotic use and excess alcohol use.
Finally, in the ﬁrst, to our knowledge, analysis among
twin pairs who were doubly discordant for smoking
and suicide, as a control for unmeasured genetic and
environmental confounding, smokingwas also strongly
associated with suicide. Thus, this report extends
ﬁndings from prior reports conducted from cohorts
with shorter follow-up periods and fewer sources
from which to control for confounders (Tanskanen
et al. 2000; Iwasaki et al. 2005; Li et al. 2012; Lucas et al.
2013; Schneider et al. 2014) and implicates tobacco
smoking as an environmental risk factor for suicide,
indicating added risk for suicide independent of prior
psychiatric and medical diagnosis or treatment.
Strengths of the study are the highly reliable,
autopsy-based suicide determination, rigorous controls
for potential confounding factors with complete,
registry-based psychiatric and medical illness diagno-
sis and treatment information, the long follow-up per-
iod for suicide outcomes that increases conﬁdence that
the observed association is not due to pre-existing con-
ditions that increase the risk of suicide, e.g. psychiatric
co-morbidity hypothesis, or to the fact that tobacco
smoking causes painful and debilitating diseases
such as cancer and increases risk for suicide through
that mechanism, e.g. the medical co-morbidity hypoth-
esis, and the ability to conduct a within-twin-pair ana-
lysis of the association.
The results support the hypothesis that chronic
exposure to tobacco smoke is an additional risk factor
for suicide that is ameliorated by smoking cessation or
reduced in those who are able to quit (Miller et al.
2000b; Hughes, 2008; Covey et al. 2012). A causal bio-
logical relationship between tobacco smoking and sui-
cide is plausible. Neurocognitive and neurobiological
evidence implicate chronic tobacco use in structural
and functional abnormalities in brain reward networks
implicated in suicide (Durazzo et al. 2010; van
Heeringen & Mann, 2014). Nicotine exposure alters
synaptic plasticity throughout the striatum, amygdala
and hippocampus, a process that reversibly affects
neurobiological processes broadly (Levine et al. 2011;
Huang et al. 2013; Kandel & Kandel, 2014).
Abnormalities in multiple systems are observed in
both smoking and suicide, including serotonergic and
receptor-linked signaling pathways (Pandey, 2013),
inﬂammatory mediators (Rom et al. 2013), and neuro-
trophins and neurotrophin receptors. Brain-derived
neurotrophic factor (BDNF) is a much studied member
of the neurotrophin family, and genetic variation in the
BDNF gene is strongly associated with smoking initi-
ation (Liu et al. 2010; Thorgeirsson et al. 2010;
Tobacco Genetics Consortium, 2010; Breetvelt et al.
2012). Further, smoking quantity, severity of nicotine
dependence and smoking cessation affect BDNF
expression levels (Bhang et al. 2010; Jamal et al. 2015;
Zhang et al. 2016). Thus, BDNF expression in the
brain is regulated by neurotransmitter systems
involved in nicotine use.
Chronic nicotine exposure has direct downstream
effects on dopaminergic and glutamatergic neurotrans-
mitter systems with roles in impulsivity and decision-
making (Durazzo et al. 2016) that are implicated in
the etiology of suicide (Kirch et al. 1987; Oquendo
et al. 2014) and which could have both independent
effects and additive effects with other static and
acute suicide risk factors, consistent with these data.
Impulsivity increases with nicotine exposure, nor-
malizes with abstinence, and recurs with re-challenge
after abstinence (Kayir et al. 2014; Kolokotroni et al.
2014). In psychiatric samples, smokers have greater
impulsivity, aggression, suicidal ideation and suicide
attempts and, among those with depression, lower
indices of serotonin function (Malone et al. 2003).
Nicotine exposure moderates the effect of dopamine
receptor gene polymorphisms on major depressive dis-
order incidence (Korhonen et al. 2014). Additionally,
tobacco smoke contains multiple other compounds
which may contribute, whose effect on central nervous
system function in humans is poorly known (US
Department of Health and Human Services, 2014).
Finally, hypoxia has been postulated as the underlying
mechanism for the association between both living at
high altitude and suicide (Kim et al. 2011) and smoking
and suicide (Aubin et al. 2011).
Whereas a strength of this study is its strong control
for potential confounders, the primary limitation is the
possibility of incomplete ascertainment of potentially
confounding factors related to both smoking and sui-
cide. We assessed contributions of indicators of diag-
nosed and undiagnosed psychiatric morbidity at two
time points with the LSS as a proxy for pre-existing
depressiveness, excess daily and binge alcohol use,
sedative–hypnotic use, unemployment, marital status,
and other demographic characteristics. We cannot
rule out entirely the possibility that these factors chan-
ged differentially in smokers v. non-smokers over the
35-year follow-up period; however, data from subsets
of the cohort presented in this paper were available
on questionnaire-based measures between 1975/1981
and 2011. Analyses of differential stability of these
risk factors from 1975/1981 to 2011 in smokers v.
never smokers did not reveal substantial change over
time in these self-report measures by smoking status.
We additionally assessed contribution of and removed
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from analyses those with psychiatric disability and
antipsychotic and antidepressant medication use over
the 35-year follow-up. For this purpose, we considered
treatment for psychiatric illness as an indicator for
diagnosed psychiatric illness. We were not able to
evaluate the impact of treatment for psychiatric illness
on suicide rates. We acknowledge that it could be
assumed that treatment for psychiatric illness would
reduce risk for suicide. Some well-established risk fac-
tors such as depression status and trauma history,
prior self-injurious thoughts and behavior in self, fam-
ily members or friends and acquaintances were not
explicitly assessed. The LSS questionnaire to assess
hopelessness, stress and isolation, all previously iden-
tiﬁed as risk factors for suicide, was used as a proxy
for pre-existing depressiveness, and those receiving
antidepressant treatment were identiﬁed. We did not
consider illicit drug use, which, in this cohort, was
rare (Agrawal et al. 2008). As expected, suicide was
strongly associated with these indicators of psychiatric
illness in this sample, and adjustment for these factors
attenuated but did not abolish the relationship
between smoking and subsequent suicide risk over
35 years. The association between smoking and suicide
observed in this study may be elevated by psychiatric
illness not captured, but it is not plausible that an
unexplained psychiatric variable associated with
tobacco smoking could be responsible entirely for a
dose-related, 2.5-fold increase in suicide rates.
Residual confounding due to imperfect information
on the known and measured confounders would
need to be more substantial than is plausible to account
for the observed strong association, given our use of
multiple sources of data. The observed effect was so
persistent that to negate the ﬁnding, an unanticipated
confounder would have to have both a very strong
effect and a very biased distribution within the sample,
making the likelihood of such a confounder highly
implausible (Kotz et al. 2015; Leone & Schnoll, 2015).
Further, in the within-pair analysis controlling for
unmeasured genetic and environmental factors, in 24
of the 28 twin pairs discordant for both smoking and
suicide, the twin that died from suicide was the smo-
ker. An experimental design in which some smokers
were assigned to become abstinent would be required
to understand whether smoking is a causal risk factor.
In this study, smoking cessation was associated with
reduced risk. However, we cannot rule out whether
person-level characteristics associated with success-
fully quitting smoking are also associated with
reduced risk for suicide. The ﬁndings are concordant
with reports that public policies that reduce smoking
on a population level are associated with reduced sui-
cide rates in locations where they are implemented
(Grucza et al. 2014), supporting a causal relationship,
but it is possible that there are societal factors in
these geographic areas that reduce suicide risk.
These results provide evidence of a strong, statistic-
ally independent, dose-related association between
smoking and completed suicide from a large, well-
controlled, population-representative cohort with the
longest follow-up to date and the ﬁrst to report a
within-twin-pair analysis of smoking and suicide.
They support and extend prior reports that active but
not former smoking is associated with suicide
(Iwasaki et al. 2005; Li et al. 2012), with heavy smoking
associated with greater suicide risk than lighter smok-
ing (Iwasaki et al. 2005). They suggest that tobacco
smoking is an environmental factor that is possibly
etiologically associated with suicide. The ﬁndings are
intriguing in light of a recent meta-analysis reporting
smoking abstinence, compared with continued smok-
ing, associated with reduced depression, anxiety, and
stress and increased positive mood and quality of
life, with effect sizes comparable with antidepressant
treatment (Taylor et al. 2014). The results support the
hypothesis that exposure to tobacco smoke is a risk
for suicide and that reduced risk of suicide is yet
another health beneﬁt of smoking cessation. Study of
chronic neurobiological effects of tobacco smoke con-
stituents may aid the effort to understand the bio-
logical underpinnings of suicide. Further study of the
clinical utility of adding smoking status to suicide
screening efforts is needed, as is further study of the
interaction between smoking and other known static
and acute risk factors for suicide, e.g. access to means
and life stressors, to build better predictive models of
suicide risk (Franklin et al. 2017).
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